MADRIGAL PHARMACEU financial statements, including revenue, expenses, profit, and loss

The total revenue of YDO1 for the last quarter is 52.69 M CHF, and it's 300.37% higher compared to the previous quarter. The net income of Q3 24 is -90.64 M CHF.